País: Austràlia
Idioma: anglès
Font: Department of Health (Therapeutic Goods Administration)
methyldopa
Alphapharm Pty Ltd
methyldopa
Medicine Listed (Export Only)
Listed (Export Only)
PULMICORT ® _Budesonide_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions ask about Pulmicort. It does not contain all the information that is known about Pulmicort. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Pulmicort against the benefits it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT PULMICORT IS USED FOR Pulmicort is inhaled into the lungs for the treatment of asthma. Asthma is a disease where the airways of your lungs become narrow and inflamed (red and swollen), making it difficult to breathe. This may be due to an allergy to house dust mites, smoke, air pollution or other things that irritate your lungs. Pulmicort contains budesonide. This belongs to a family of medicines called corticosteroids, which are used to reduce inflammation in many parts of the body. Pulmicort acts directly on your airways to reduce inflammation. This helps to improve your condition and to prevent asthma attacks from occurring. It is a "preventer" and needs to be taken regularly. Pulmicort may also be used to treat croup in infants and children. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY PULMICORT HAS BEEN PRESCRIBED FOR YOU. Your doctor may prescribe it for another reason. Pulmicort is not addictive. Pulmicort is available only with a doctor's prescription. BEFORE YOU USE PULMICORT _WHEN YOU MUST NOT USE IT_ DO NOT USE PULMICORT IF YOU HAVE AN ALLERGY TO: • any medicine containing budesonide • any ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • rash, itching or hives on the skin • shortness of breath, wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body. DO NOT USE PULMICORT AFTER THE EXPIRY DATE (EXP) PRINTED ON THE PACK O Llegiu el document complet
1 of 12 AUSTRALIAN PRODUCT INFORMATION PULMICORT ® TURBUHALER ® & PULMICORT ® RESPULES ® (BUDESONIDE) 1 NAME OF THE MEDICINE Budesonide 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _Pulmicort Turbuhaler:_ Pulmicort Turbuhaler contains only budesonide as the active ingredient; either 100 μg, 200 μg or 400 μg per dose (metered dose). _Pulmicort Respules_ : Pulmicort Respules contain budesonide 0.5 mg in 2 mL or 1 mg in 2 mL as the active ingredient. For the full list of Pulmicort Respules excipients, see Section 6.1. 3 PHARMACEUTICAL FORM _Pulmicort Turbuhaler:_ powder for inhalation. Pulmicort Turbuhaler is a breath activated multiple dose dry powder inhaler. _Pulmicort Respules_ : Pulmicort Respules nebulising suspension for inhalation is a white to off- white suspension in plastic single dose units. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of bronchial asthma. Pulmicort may also be used when replacement or reduction in oral steroid therapy is desirable. Pulmicort Respules can be used for the treatment of acute laryngotracheobronchitis (croup) in infants and children. 4.2 DOSE AND METHOD OF ADMINISTRATION BRONCHIAL ASTHMA _PULMICORT TURBUHALER _ _Initially, or during periods of severe asthma or while reducing oral corticosteroids _ _Adults: _ 400 to 2400 μg daily divided into 2 to 4 administrations. In less severe cases 400 to 800 μg daily may be sufficient. Once daily dosing may be considered in adult patients with mild asthma who require a dose of up to 400 μg budesonide per day. The dose may then be given either in the morning or the evening. _Children: _ 200 to 400 μg daily, divided into 2 to 4 administrations. Severe cases may require daily doses up to 800 μg. This dose has been reported not to affect adrenal function in children. 2 of 12 _Maintenance _ The maintenance dose should be individualised and should be the lowest dose, which leaves the patient symptom-free. Recommended doses are 100-400 μg daily; this may be given as a twice daily dose, or as a once daily dose given i Llegiu el document complet